TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Norsk Diabetessenter For Behandling og Opplæring
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
13,206
|
12,426
|
10,974 |
Financial expenses |
2
|
0
|
5 |
Earnings before taxes |
-650
|
380
|
170 |
Total assets |
15,981
|
16,351
|
14,652 |
Current assets |
10,676
|
11,056
|
9,576 |
Current liabilities |
2,143
|
2,298
|
1,922 |
Equity capital |
13,838
|
14,053
|
12,729 |
- share capital |
116
|
113
|
105 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
86.6%
|
85.9%
|
86.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
-4.9%
|
3.1%
|
1.5% |
Return on assets (ROA) |
-4.1%
|
2.3%
|
1.2% |
Current ratio |
498.2%
|
481.1%
|
498.2% |
Return on equity (ROE) |
-4.7%
|
2.7%
|
1.3% |
Change turnover |
395
|
638
|
-401 |
Change turnover % |
3%
|
5%
|
-4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.